학술논문

Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma
Document Type
Article
Source
In: Cancer Immunology, Immunotherapy. (Cancer Immunology, Immunotherapy, July 2023, 72(7):2057-2065)
Subject
Language
English
ISSN
14320851
03407004